The global vaginitis therapeutics market is entering an accelerated growth phase, driven by rising awareness of women’s health, advances in treatment options, and increasing investments in research and development. According to industry data, the market size was valued at USD 3,840.0 million in 2023 and is expected to expand from USD 4,109.2 million in 2024 to USD 6,820.3 million by 2031....
English
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά
Tiếng Việt